SARRP 200 Small animal radiation research platform

SARRP 200 小动物辐射研究平台

基本信息

  • 批准号:
    8826303
  • 负责人:
  • 金额:
    $ 59.97万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-03-23 至 2016-03-22
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): This shared instrument application is to support the purchase of a small animal radiation research platform (SARRP). The technology available from Xstrahl is unique and combines a cone beam CT with a computer controlled rotating treatment x-ray tube. In combination with the treatment planning software, this hardware allows for 3-dimensional radiotherapy treatment planning and delivery to model organisms that mimics the volumetric approach used to treat human tumors. This next-generation system leverages the recent advances in small animal CT to generate true image guided radiotherapy, or IGRT. The device incorporates a 360o rotating gantry with a stage that rotates and translates in 3 dimensions to allow for multiple x-ray beamlets to be delivered from any angle and converge upon the tumor. This system will replace the current technology at Ohio State University that is based on 50 year old design for cabinet X-ray machines. The cabinet x-ray device at Ohio State University is an RS2000, a point source X-ray generator fixed to the top of a sealed cabinet. In order to treat animals, one must use manual placement of lead shielding in such a way as to shield a portion of the mouse and allow x-ray delivery only to the model tumor. The SARRP will enhance the research of 6 major users with 9 currently funded NIH projects that span the departments of Radiation Oncology, Neurosurgery, and Molecular Virology, Immunology and Medical Genetics at OSUCCC and the Experimental Therapeutics program at Nationwide Children's Research Institute. In addition, the SARRP device will be incorporated into the training for the graduate program in medical physics run in the department of Radiation Oncology. Finally, the SARRP will be combined into the services that are offered at the OSU Neuroscience Center (P30) core for orthotopic brain tumor implantation. This core is designed to support the development of new technologies for the treatment of brain tumors. Current and future investigators using this core will now be able to incorporate radiotherapy with their novel modalities in the hope of generating innovative, synergistic therapeutics to treat brain tumors.
 说明(申请人提供):本次共享仪器申请是为了支持购买小动物辐射研究平台(SARRP)。Xstrahl提供的技术是独一无二的,它将锥形束CT与计算机控制的旋转治疗X射线管相结合。与治疗计划软件相结合,这种硬件允许进行三维放射治疗计划,并将其提供给模仿用于治疗人类肿瘤的体积方法的模型生物。这一新一代系统利用小动物CT的最新进展来产生真正的图像引导放射治疗,或称IGRT。该设备结合了一个360度旋转龙门和一个可在3个维度上旋转和平移的工作台,以允许从任何角度输送多个X射线束并汇聚到肿瘤上。该系统将取代俄亥俄州立大学目前的技术,该技术基于已有50年历史的机柜X光机设计。俄亥俄州立大学的机柜X射线设备是RS2000,这是一个固定在密封机柜顶部的点源X射线发生器。为了治疗动物,人们必须使用手动放置铅屏蔽物的方式,以屏蔽小鼠的一部分,并只允许X射线传输到模型肿瘤。SARRP将通过目前资助的9个NIH项目加强6个主要用户的研究,这些项目横跨OSUCCC的放射肿瘤学、神经外科、分子病毒学、免疫学和医学遗传学部门,以及全国儿童研究所的实验治疗计划。此外,SARRP设备将被纳入放射肿瘤学系医学物理学研究生课程的培训中。最后,SARRP将被合并到俄亥俄州立大学神经科学中心(P30)核心提供的原位脑瘤植入服务中。这一核心旨在支持脑瘤治疗新技术的开发。目前和未来使用这一核心的研究人员现在将能够将放射治疗与他们的新模式结合起来,希望产生创新的、协同的疗法来治疗脑瘤。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Nicholas C. Denko其他文献

Hypoxia, HIF1 and glucose metabolism in the solid tumour
实体瘤中的缺氧、HIF1 与葡萄糖代谢
  • DOI:
    10.1038/nrc2468
  • 发表时间:
    2008-08-14
  • 期刊:
  • 影响因子:
    66.800
  • 作者:
    Nicholas C. Denko
  • 通讯作者:
    Nicholas C. Denko
Hypoxic gene expression and metastasis
  • DOI:
    10.1023/b:canc.0000031768.89246.d7
  • 发表时间:
    2004-08-01
  • 期刊:
  • 影响因子:
    8.700
  • 作者:
    Quynh-Thu Le;Nicholas C. Denko;Amato J. Giaccia
  • 通讯作者:
    Amato J. Giaccia

Nicholas C. Denko的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Nicholas C. Denko', 18)}}的其他基金

Overcoming Hypoxic Resistance in Non-Small Cell Lung Cancer By Targeting Mitochondrial Metabolism
通过靶向线粒体代谢克服非小细胞肺癌的缺氧抵抗
  • 批准号:
    10275968
  • 财政年份:
    2021
  • 资助金额:
    $ 59.97万
  • 项目类别:
Overcoming Hypoxic Resistance in Non-Small Cell Lung Cancer By Targeting Mitochondrial Metabolism
通过靶向线粒体代谢克服非小细胞肺癌的缺氧抵抗
  • 批准号:
    10704677
  • 财政年份:
    2021
  • 资助金额:
    $ 59.97万
  • 项目类别:
Diversity Supplement R01CA262388: Overcoming Hypoxic Resistance in Non-Small Cell Lung Cancer By Targeting Mitochondrial Metabolism
多样性补充剂 R01CA262388:通过靶向线粒体代谢克服非小细胞肺癌的缺氧抵抗
  • 批准号:
    10595436
  • 财政年份:
    2021
  • 资助金额:
    $ 59.97万
  • 项目类别:
Overcoming Hypoxic Resistance in Non-Small Cell Lung Cancer By Targeting Mitochondrial Metabolism
通过靶向线粒体代谢克服非小细胞肺癌的缺氧抵抗
  • 批准号:
    10737837
  • 财政年份:
    2021
  • 资助金额:
    $ 59.97万
  • 项目类别:
Overcoming hypoxic resistance to anti-cancer therapy
克服抗癌治疗的缺氧抵抗
  • 批准号:
    10318987
  • 财政年份:
    2020
  • 资助金额:
    $ 59.97万
  • 项目类别:
Overcoming hypoxic resistance to anti-cancer therapy
克服抗癌治疗的缺氧抵抗
  • 批准号:
    10531898
  • 财政年份:
    2020
  • 资助金额:
    $ 59.97万
  • 项目类别:
A phase 0 pilot study to determine if papaverine increases oxygenation in spontaneous canine soft tissue sarcoma
一项 0 期试点研究,以确定罂粟碱是否会增加自发性犬软组织肉瘤的氧合
  • 批准号:
    9985010
  • 财政年份:
    2019
  • 资助金额:
    $ 59.97万
  • 项目类别:
Decreasing oxygen metabolism to redcue hypoxia and radiosensitize tumors.
减少氧代谢以减少缺氧并使肿瘤放射增敏。
  • 批准号:
    8703638
  • 财政年份:
    2012
  • 资助金额:
    $ 59.97万
  • 项目类别:
Decreasing oxygen metabolism to redcue hypoxia and radiosensitize tumors.
减少氧代谢以减少缺氧并使肿瘤放射增敏。
  • 批准号:
    8700567
  • 财政年份:
    2012
  • 资助金额:
    $ 59.97万
  • 项目类别:
Decreasing oxygen metabolism to redcue hypoxia and radiosensitize tumors.
减少氧代谢以减少缺氧并使肿瘤放射增敏。
  • 批准号:
    8550788
  • 财政年份:
    2012
  • 资助金额:
    $ 59.97万
  • 项目类别:

相似海外基金

Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
  • 批准号:
    495434
  • 财政年份:
    2023
  • 资助金额:
    $ 59.97万
  • 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
  • 批准号:
    10642519
  • 财政年份:
    2023
  • 资助金额:
    $ 59.97万
  • 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
  • 批准号:
    10586596
  • 财政年份:
    2023
  • 资助金额:
    $ 59.97万
  • 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
  • 批准号:
    10590479
  • 财政年份:
    2023
  • 资助金额:
    $ 59.97万
  • 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
  • 批准号:
    23K06011
  • 财政年份:
    2023
  • 资助金额:
    $ 59.97万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
  • 批准号:
    10682117
  • 财政年份:
    2023
  • 资助金额:
    $ 59.97万
  • 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
  • 批准号:
    10708517
  • 财政年份:
    2023
  • 资助金额:
    $ 59.97万
  • 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
  • 批准号:
    10575566
  • 财政年份:
    2023
  • 资助金额:
    $ 59.97万
  • 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
  • 批准号:
    23K15696
  • 财政年份:
    2023
  • 资助金额:
    $ 59.97万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
  • 批准号:
    23K15867
  • 财政年份:
    2023
  • 资助金额:
    $ 59.97万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了